FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrea Cavazzoni

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cell Line

Disorders

Physiology

Drug Resistance, Neoplasm

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Elena Galvani; Elisa Giovannetti; Leticia G Leon; Marco Mor; Roberta Alfieri; Andrea Ardizzoni; Caterina Carmi; Andrea Cavazzoni; Henk Dekker; Pier Giorgio Petronini; Francesca Saccani; Godefridus J Peters
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.
Elena Galvani; Elisa Giovannetti; Silvia La Monica; Marco Mor; Godefridus J Peters; Pier Giorgio Petronini; Marcello Tiseo; Mara Bonelli; Andrea Cavazzoni; Claudia Fumarola; Maricla Galetti; Roberta Alfieri; Andrea Ardizzoni
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.
Andrea Cavazzoni; Claudia Fumarola; Maricla Galetti; Elena Galvani; daniele generali; Adrian L Harris; Silvia La Monica; Lesley-Ann Martin; Kinda Airoud; Roberta R Alfieri; Daniele Andreis; Ramona Bertoni; Mara A Bonelli; Alberto Bottini; Stefano Tramonti; Pier Giorgio Petronini
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrea Cavazzoni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elena Galvani; Elisa Giovannetti; Leticia G Leon; Marco Mor; Roberta Alfieri; Andrea Ardizzoni; Caterina Carmi; Andrea Cavazzoni; Henk Dekker; Pier Giorgio Petronini; Francesca Saccani; Godefridus J Peters
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.
Neoplasia (New York, N.Y.) 2013;15(1):61-72.
2013: Elena Galvani; Elisa Giovannetti; Silvia La Monica; Marco Mor; Godefridus J Peters; Pier Giorgio Petronini; Marcello Tiseo; Mara Bonelli; Andrea Cavazzoni; Claudia Fumarola; Maricla Galetti; Roberta Alfieri; Andrea Ardizzoni
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.
Current pharmaceutical design 2013;19(5):818-32.
2012: Andrea Cavazzoni; Claudia Fumarola; Maricla Galetti; Elena Galvani; daniele generali; Adrian L Harris; Silvia La Monica; Lesley-Ann Martin; Kinda Airoud; Roberta R Alfieri; Daniele Andreis; Ramona Bertoni; Mara A Bonelli; Alberto Bottini; Stefano Tramonti; Pier Giorgio Petronini
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones.
Cancer letters 2012;323(1):77-87.
2012: Caterina Carmi; Andrea Cavazzoni; Gabriele Costantino; Elena Galvani; Alessio Lodola; Stefania Aiello; Roberta R Alfieri; Andrea Ardizzoni; Fabrizio Bordi; Pier Giorgio Petronini; Silvia Rivara; Simonetta Russo; Federica Vacondio; Marco Mor
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides.
Journal of medicinal chemistry 2012;55(5):2251-64.
2012: Andrea Cavazzoni; Daniele Cretella; Claudia Fumarola; Maricla Galetti; Elena Galvani; Gallia Graiani; Silvia La Monica; Denise Madeddu; Paola Mozzoni; Antonio Mutti; Pier Giorgio Petronini; Federico Quaini; Francesca Saccani; Marcello Tiseo; Roberta R Alfieri; Luca Ampollini; Elisabetta Barocelli; Mara Bonelli; Paolo Carbognani; Andrea Ardizzoni
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines.
Molecular cancer 2012;11():91.
2011: Salah A Al-Trawneh; Mustafa M el-Abadelah; Jalal A Zahra; Samir A Al-Taweel; Franca Zani; Matteo Incerti; Andrea Cavazzoni; Paola Vicini
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.
Bioorganic & medicinal chemistry 2011;19(8):2541-8.
2011: Roberta R Alfieri; Roberta Andreoli; Andrea Ardizzoni; Mara Bonelli; Andrea Cavazzoni; giuseppe de palma; Claudia Fumarola; Maricla Galetti; Elena Galvani; Silvia La Monica; Ettore Mari; Marco Mor; Paola Mozzoni; Antonio Mutti; Marcello Tiseo; Stefano Tramonti; Pier Giorgio Petronini
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.
Molecular cancer 2011;10():143.
2010: Salah A Al-Trawneh; Jalal A Zahra; Marwan R Kamal; Mustafa M el-Abadelah; Franca Zani; Matteo Incerti; Andrea Cavazzoni; Roberta R Alfieri; Pier G Petronini; Paola Vicini
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.
Bioorganic & medicinal chemistry 2010;18(16):5873-84.
2010: Luca Ampollini; Fabio Sonvico; Elisabetta Barocelli; Andrea Cavazzoni; Rocco Bilancia; Claudio Mucchino; Anna Maria Cantoni; Paolo Carbognani
Intrapleural polymeric films containing cisplatin for malignant pleural mesothelioma in a rat tumour model: a preliminary study.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2010;37(3):557-65.
2008: Marcello Tiseo; Marzia Capelletti; giuseppe de palma; Vittorio Franciosi; Andrea Cavazzoni; Paola Mozzoni; Roberta R Alfieri; Matteo Goldoni; Maricla Galetti; Beatrice Bortesi; Cecilia Bozzetti; Maura Loprevite; Luca Boni; Roberta Camisa; Guido Rindi; Pier Giorgio Petronini; Andrea Ardizzoni
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(10):1104-11.